|
1
|
Libby P: Inflammation in atherosclerosis.
Nature. 420:868–874. 2002.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Virani SS, Alonso A, Benjamin EJ,
Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR,
Cheng S, Delling FN, et al: Heart disease and stroke
statistics-2020 update: A report from the American heart
association. Circulation. 141:e139–e596. 2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Tabas I and Bornfeldt KE: Macrophage
phenotype and function in different stages of atherosclerosis. Circ
Res. 118:653–667. 2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Murray PJ: Macrophage polarization. Annu
Rev Physiol. 79:541–566. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Mantovani A, Garlanda C and Locati M:
Macrophage diversity and polarization in atherosclerosis: A
question of balance. Arterioscler Thromb Vasc Biol. 29:1419–1423.
2009.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Sica A and Mantovani A: Macrophage
plasticity and polarization: In vivo veritas. J Clin Invest.
122:787–795. 2012.PubMed/NCBI View
Article : Google Scholar
|
|
7
|
Leitinger N and Schulman IG: Phenotypic
polarization of macrophages in atherosclerosis. Arterioscler Thromb
Vasc Biol. 33:1120–1126. 2013.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Tall AR, Yvan-Charvet L, Terasaka N,
Pagler T and Wang N: HDL, ABC transporters, and cholesterol efflux:
Implications for the treatment of atherosclerosis. Cell Metab.
7:365–375. 2008.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Tall AR and Yvan-Charvet L: Cholesterol,
inflammation and innate immunity. Nat Rev Immunol. 15:104–116.
2015.PubMed/NCBI View
Article : Google Scholar
|
|
10
|
Gleissner CA, Shaked I, Little KM and Ley
K: CXC chemokine ligand 4 induces a unique transcriptome in
monocyte-derived macrophages. J Immunol. 184:4810–4818.
2010.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Finn AV, Nakano M, Polavarapu R, Karmali
V, Saeed O, Zhao X, Yazdani S, Otsuka F, Davis T, Habib A, et al:
Hemoglobin directs macrophage differentiation and prevents foam
cell formation in human atherosclerotic plaques. J Am Coll Cardiol.
59:166–177. 2012.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Tabas I: Macrophage death and defective
inflammation resolution in atherosclerosis. Nat Rev Immunol.
10:36–46. 2010.PubMed/NCBI View
Article : Google Scholar
|
|
13
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297.
2004.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Xu P, Guo M and Hay BA: MicroRNAs and the
regulation of cell death. Trends Genet. 20:617–624. 2004.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Divakaran V and Mann DL: The emerging role
of microRNAs in cardiac remodeling and heart failure. Circ Res.
103:1072–1083. 2008.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Yang CL, Zheng XL, Ye K, Ge H, Sun YN, Lu
YF and Fan QX: MicroRNA-183 Acts as a tumor suppressor in human
non-small cell lung cancer by down-regulating MTA1. Cell Physiol
Biochem. 46:93–106. 2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Yang X, Wang L, Wang Q, Li L, Fu Y and Sun
J: miR-183 inhibits osteosarcoma cell growth and invasion by
regulating LRP6-Wnt/β-catenin signaling pathway. Biochem Biophys
Res Commun. 496:1197–1203. 2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Wei C, Song H, Sun X, Li D, Song J, Hua K
and Fang L: miR-183 regulates biological behavior in papillary
thyroid carcinoma by targeting the programmed cell death 4. Oncol
Rep. 34:211–220. 2015.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Chen C, Ponnusamy M, Liu C, Gao J, Wang K
and Li P: MicroRNA as a therapeutic target in cardiac remodeling.
Biomed Res Int. 2017(1278436)2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zhang Y, Zhan Y, Liu D and Yu B:
Inhibition of microRNA-183 expression resists human umbilical
vascular endothelial cells injury by upregulating expression of
IRS1. Drug Deliv. 26:612–621. 2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Kim M, Jo H, Kwon Y, Kim Y, Jung HS and
Jeoung D: Homoharringtonine inhibits allergic inflammations by
regulating NF-κB-miR-183-5p-BTG1 axis. Front Pharmacol.
11(1032)2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Krausgruber T, Blazek K, Smallie T,
Alzabin S, Lockstone H, Sahgal N, Hussell T, Feldmann M and Udalova
IA: IRF5 promotes inflammatory macrophage polarization and TH1-TH17
responses. Nat Immunol. 12:231–238. 2011.PubMed/NCBI View
Article : Google Scholar
|
|
24
|
Liao X, Sharma N, Kapadia F, Zhou G, Lu Y,
Hong H, Paruchuri K, Mahabeleshwar GH, Dalmas E, Venteclef N, et
al: Kruppel-like factor 4 regulates macrophage polarization. J Clin
Invest. 121:2736–2749. 2011.PubMed/NCBI View
Article : Google Scholar
|
|
25
|
Liu H, Cheng WL, Jiang X, Wang PX, Fang C,
Zhu XY, Huang Z, She ZG and Li H: Ablation of interferon regulatory
factor 3 protects against atherosclerosis in apolipoprotein
E-deficient mice. Hypertension. 69:510–520. 2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Wang PX, Ji YX, Zhang XJ, Zhao LP, Yan ZZ,
Zhang P, Shen LJ, Yang X, Fang J, Tian S, et al: Targeting CASP8
and FADD-like apoptosis regulator ameliorates nonalcoholic
steatohepatitis in mice and nonhuman primates. Nat Med. 23:439–449.
2017.PubMed/NCBI View
Article : Google Scholar
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Arner P and Kulyte A: MicroRNA regulatory
networks in human adipose tissue and obesity. Nat Rev Endocrinol.
11:276–288. 2015.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Nazari-Jahantigh M, Egea V, Schober A and
Weber C: MicroRNA-specific regulatory mechanisms in
atherosclerosis. J Mol Cell Cardiol. 89:35–41. 2015.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Schober A, Nazari-Jahantigh M and Weber C:
MicroRNA-mediated mechanisms of the cellular stress response in
atherosclerosis. Nat Rev Cardiol. 12:361–374. 2015.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Tana C, Giamberardino MA and Cipollone F:
microRNA profiling in atherosclerosis, diabetes, and migraine. Ann
Med. 49:93–105. 2017.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Wang H and Cai J: The role of microRNAs in
heart failure. Biochim Biophys Acta Mol Basis Dis. 1863:2019–2030.
2017.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Zhang L, Miller D, Yang Q and Wu B:
MicroRNA regulatory networks as biomarkers in obesity: The emerging
role. Methods Mol Biol. 1617:241–260. 2017.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Li C, Qu L, Farragher C, Vella A and Zhou
B: MicroRNA regulated macrophage activation in obesity. J Transl
Int Med. 7:46–52. 2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Lusis AJ: Atherosclerosis. Nature.
407:233–241. 2000.PubMed/NCBI View
Article : Google Scholar
|
|
36
|
Banerjee S, Xie N, Cui H, Tan Z, Yang S,
Icyuz M, Abraham E and Liu G: MicroRNA let-7c regulates macrophage
polarization. J Immunol. 190:6542–6549. 2013.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Ouimet M, Ediriweera HN, Gundra UM, Sheedy
FJ, Ramkhelawon B, Hutchison SB, Rinehold K, van Solingen C,
Fullerton MD, Cecchini K, et al: MicroRNA-33-dependent regulation
of macrophage metabolism directs immune cell polarization in
atherosclerosis. J Clin Invest. 125:4334–4348. 2015.PubMed/NCBI View
Article : Google Scholar
|
|
38
|
Ying W, Tseng A, Chang RC, Morin A, Brehm
T, Triff K, Nair V, Zhuang G, Song H, Kanameni S, et al:
MicroRNA-223 is a crucial mediator of PPARγ-regulated alternative
macrophage activation. J Clin Invest. 125:4149–4159.
2015.PubMed/NCBI View
Article : Google Scholar
|
|
39
|
Qiu M, Ma J, Zhang J, Guo X, Liu Q and
Yang Z: MicroRNA-150 deficiency accelerates intimal hyperplasia by
acting as a novel regulator of macrophage polarization. Life Sci.
240(116985)2020.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Takeuchi H, Tanaka M, Tanaka A, Tsunemi A
and Yamamoto H: Predominance of M2-polarized macrophages in bladder
cancer affects angiogenesis, tumor grade and invasiveness. Oncol
Lett. 11:3403–3408. 2016.PubMed/NCBI View Article : Google Scholar
|
|
41
|
McMorrow JP and Murphy EP: Inflammation: A
role for NR4A orphan nuclear receptors? Biochem Soc Trans.
39:688–693. 2011.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Pei L, Castrillo A and Tontonoz P:
Regulation of macrophage inflammatory gene expression by the orphan
nuclear receptor Nur77. Mol Endocrinol. 20:786–794. 2006.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Hanna RN, Shaked I, Hubbeling HG, Punt JA,
Wu R, Herrley E, Zaugg C, Pei H, Geissmann F, Ley K and Hedrick CC:
NR4A1 (Nur77) deletion polarizes macrophages toward an inflammatory
phenotype and increases atherosclerosis. Circ Res. 110:416–427.
2012.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Qing H, Liu Y, Zhao Y, Aono J, Jones KL,
Heywood EB, Howatt D, Binkley CM, Daugherty A, Liang Y and Bruemmer
D: Deficiency of the NR4A orphan nuclear receptor NOR1 in
hematopoietic stem cells accelerates atherosclerosis. Stem Cells.
32:2419–2429. 2014.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Qing H, Jones KL, Heywood EB, Lu H,
Daugherty A and Bruemmer D: Deletion of the NR4A nuclear receptor
NOR1 in hematopoietic stem cells reduces inflammation but not
abdominal aortic aneurysm formation. BMC Cardiovasc Disord.
17(271)2017.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Hamers AA, Hanna RN, Nowyhed H, Hedrick CC
and de Vries CJ: NR4A nuclear receptors in immunity and
atherosclerosis. Curr Opin Lipidol. 24:381–385. 2013.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Mahajan S, Saini A, Chandra V, Nanduri R,
Kalra R, Bhagyaraj E, Khatri N and Gupta P: Nuclear Receptor Nr4a2
promotes alternative polarization of macrophages and confers
protection in sepsis. J Biol Chem. 290:18304–18314. 2015.PubMed/NCBI View Article : Google Scholar
|
